ClinVar Miner

Submissions for variant NM_000021.4(PSEN1):c.1141C>T (p.Leu381Phe)

dbSNP: rs63750687
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Undiagnosed Diseases Network, NIH RCV000625969 SCV000746567 likely pathogenic Alzheimer disease 3 2017-11-17 criteria provided, single submitter clinical testing Variant found to segregate in proband's affected father, uncles, grandfather. The family has been published by another group in PMID:24121961.
Labcorp Genetics (formerly Invitae), Labcorp RCV003764803 SCV004570950 likely pathogenic Alzheimer disease 3; Frontotemporal dementia; Pick disease; Acne inversa, familial, 3 2023-11-04 criteria provided, single submitter clinical testing This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 381 of the PSEN1 protein (p.Leu381Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of early-onset Alzheimer disease (PMID: 24121961; Invitae). ClinVar contains an entry for this variant (Variation ID: 120170). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PSEN1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PSEN1 function (PMID: 35365805). This variant disrupts the p.Leu381 amino acid residue in PSEN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27930341, 34776449). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
OMIM RCV000106293 SCV000143752 pathogenic Alzheimer disease familial 3, with spastic paraparesis 2014-01-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.